In tackling high drug prices, FTC shows partisan split
Combating unreasonable, unilateral drug price hikes is a big talking point on the presidential campaign trail. But when lawmakers asked the Federal Trade Commission about whether it could help, the commissioners...To view the full article, register now.
Already a subscriber? Click here to view full article